The DOI matches its Crossref record.
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
Abstract
BACKGROUND: Vitamin D compounds are widely used to prevent and treat secondary hyperparathyroidism. PURPOSE: To determine whether vitamin D therapy improves biochemical markers of mineral metabolism and cardiovascular and mortality outcomes in chronic kidney disease. DATA SOURCES: MEDLINE (January 1966 to July 2007), EMBASE (January 1980 to July 2007), and Cochrane databases were searched without language restriction. STUDY SELECTION: Randomized, controlled trials of vitamin D compounds in chronic kidney disease were identified. DATA EXTRACTION: Two authors independently extracted data. DATA SYNTHESIS: Seventy-six trials were identified for inclusion; 3667 participants were enrolled. Vitamin D compounds did not reduce the risk for death, bone pain, vascular calcification, or parathyroidectomy. Compared with placebo, established vitamin D sterols were associated with an increased risk for hypercalcemia (relative risk, 2.37 [95% CI, 1.16 to 4.85]) and hyperphosphatemia (relative risk, 1.77 [CI, 1.15 to 2.74]) but did not show a consistent reduction in parathyroid hormone (PTH) levels. Compared with placebo, more recently developed vitamin D analogues were associated with hypercalcemia (relative risk, 5.15 [CI, 1.06 to 24.97]) but not hyperphosphatemia, and levels of PTH were reduced (weighted mean difference, -10.77 pmol/L [CI, -20.51 to -1.03 pmol/L]). For suppression of PTH, intravenous administration was superior to oral vitamin D, but higher intravenous doses were used. LIMITATIONS: Few studies reported patient-level outcomes, including mortality (8 of 76 trials), and only 5 trials directly compared the effects of treatment with newer vitamin D compounds versus established ones. Heterogeneity in some comparisons remained unexplained by metaregression analyses. CONCLUSION: Vitamin D compounds do not consistently reduce PTH levels, and beneficial effects on patient-level outcomes are unproven. The value of vitamin D treatment for people with chronic kidney disease remains uncertain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Associations between Hemodialysis Access Type and Clinical Outcomes: A Systematic Review
Ravani, P., Palmer, S. C., Oliver, M. J., Quinn, R. R., MacRae, J. M., Tai, D. J., Pannu, N. I., Thomas, C., Hemmelgarn, B. R., Craig, J. C., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070643 · Cited by 738
Self-citationPalmer, S. C. (2011) · JAMA · doi:10.1001/jama.2011.308 · Cited by 721
Self-citationEffect of vitamin D on blood pressure: a systematic review and meta-analysis
Witham, M. D., Nadir, M. A., & Struthers, A. D. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832f075b · Cited by 400
Bone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Alborzi, P., Patel, N. A., Peterson, C., Bills, J. E., Bekele, D. M., Bunaye, Z., Light, R. P., & Agarwal, R. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.113159 · Cited by 331
Metadata
- Authors
- Palmer, S. C., McGregor, D. O., Macaskill, P., Craig, J. C., Elder, G. J., & Strippoli, G. F. M.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-12-18
- Volume
- 147
- Issue
- 12
- Pages
- 840-853
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2014855190
- Cited by
- 251
- References
- 0
- FWCI
- 19.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease. https://app.cochat.ai/papers/10.7326/0003-4819-147-12-200712180-00004
- The paper
- Palmer, S. C., McGregor, D. O., Macaskill, P., Craig, J. C., Elder, G. J., & Strippoli, G. F. M. (2007). Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-147-12-200712180-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.